[go: up one dir, main page]

AU2001264769A1 - Induction of apoptosis and cell growth inhibition by protein 4.33 - Google Patents

Induction of apoptosis and cell growth inhibition by protein 4.33

Info

Publication number
AU2001264769A1
AU2001264769A1 AU2001264769A AU6476901A AU2001264769A1 AU 2001264769 A1 AU2001264769 A1 AU 2001264769A1 AU 2001264769 A AU2001264769 A AU 2001264769A AU 6476901 A AU6476901 A AU 6476901A AU 2001264769 A1 AU2001264769 A1 AU 2001264769A1
Authority
AU
Australia
Prior art keywords
apoptosis
induction
protein
cell growth
growth inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264769A
Inventor
Angela Ranae Ingermann
Youngman Oh
Ron Rosenfeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health and Science University
Original Assignee
Oregon Health and Science University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Health and Science University filed Critical Oregon Health and Science University
Publication of AU2001264769A1 publication Critical patent/AU2001264769A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AU2001264769A 2000-05-17 2001-05-17 Induction of apoptosis and cell growth inhibition by protein 4.33 Abandoned AU2001264769A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20494900P 2000-05-17 2000-05-17
US60204949 2000-05-17
PCT/US2001/016437 WO2001087238A2 (en) 2000-05-17 2001-05-17 Induction of apoptosis and cell growth inhibition by protein 4.33

Publications (1)

Publication Number Publication Date
AU2001264769A1 true AU2001264769A1 (en) 2001-11-26

Family

ID=22760142

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264769A Abandoned AU2001264769A1 (en) 2000-05-17 2001-05-17 Induction of apoptosis and cell growth inhibition by protein 4.33

Country Status (5)

Country Link
US (2) US7585497B2 (en)
EP (1) EP1290162A4 (en)
AU (1) AU2001264769A1 (en)
CA (1) CA2410056A1 (en)
WO (1) WO2001087238A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1290162A4 (en) * 2000-05-17 2005-08-17 Univ Oregon Health Sciences INDUCTION OF APOPTOSIS AND INHIBITION OF CELL GROWTH THROUGH 4.33 PROTEIN
WO2002034916A2 (en) 2000-10-27 2002-05-02 Oregon Health And Science University Novel mutant igbp-3 molecules that do not bind to igfs, but retain their ability to functionally bind igfbp-3 receptor
DE60224419D1 (en) 2001-09-18 2008-02-14 Bioexpertise Llc OF IGF BINDING PROTEIN STRAINING PEPTIDE
US6887851B2 (en) 2001-09-18 2005-05-03 Bioexpertise, Llc IGF-binding protein-derived peptide
US6914049B2 (en) 2001-09-18 2005-07-05 Bioexpertise, Llc IGF-binding protein-derived peptide or small molecule
ATE453723T1 (en) * 2001-12-31 2010-01-15 Dana Farber Cancer Inst Inc PSORIASIN EXPRESSION BY BREAST EPITHELIAL CELLS
AU2004278311A1 (en) 2003-10-03 2005-04-14 Genentech, Inc. IGF binding proteins
AR064464A1 (en) * 2006-12-22 2009-04-01 Genentech Inc ANTIBODIES ANTI - INSULINAL GROWTH FACTOR RECEIVER
EP2068276A1 (en) * 2007-12-04 2009-06-10 Sony Corporation Information processing device and method, program, and recording medium
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy
US20140286966A1 (en) * 2010-07-06 2014-09-25 Youngman Oh Methods and compositions for the treatment of metabolic syndrome, obstructive respiratory disorders, cancer and related diseases
US10842849B2 (en) * 2011-02-28 2020-11-24 The Schepens Eye Research Institute, Inc. Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
NZ738389A (en) 2015-06-04 2019-02-22 Ospedale San Raffaele Srl Inhibitor of igfbp3/tmem219 axis and diabetes
PL3302520T3 (en) * 2015-06-04 2021-03-22 Ospedale San Raffaele S.R.L. Igfbp3 and uses thereof
KR102594780B1 (en) * 2016-11-01 2023-10-26 버지니아 커먼웰스 유니버시티 Treatment of diseases related to IGFB3 and its receptors
EP3632929A1 (en) 2018-10-02 2020-04-08 Ospedale San Raffaele S.r.l. Antibodies and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215051A (en) 1979-08-29 1980-07-29 Standard Oil Company (Indiana) Formation, purification and recovery of phthalic anhydride
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
EP0633318A1 (en) 1987-09-11 1995-01-11 Whitehead Institute For Biomedical Research Transduced fibroblasts and uses therefor
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5399349A (en) 1992-02-06 1995-03-21 Paunescu; Calin Treatment of acne
US5840673A (en) * 1995-09-14 1998-11-24 Bristol-Myers Squibb Company Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of p53-related tumors
US6534631B1 (en) * 1998-07-15 2003-03-18 Human Genome Sciences, Inc. Secreted protein HT5GJ57
US7368531B2 (en) * 1997-03-07 2008-05-06 Human Genome Sciences, Inc. Human secreted proteins
US7411051B2 (en) * 1997-03-07 2008-08-12 Human Genome Sciences, Inc. Antibodies to HDPPA04 polypeptide
DE19818619A1 (en) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents
WO1999061471A2 (en) * 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Human transmembrane proteins
US7368527B2 (en) * 1999-03-12 2008-05-06 Human Genome Sciences, Inc. HADDE71 polypeptides
EP1290162A4 (en) * 2000-05-17 2005-08-17 Univ Oregon Health Sciences INDUCTION OF APOPTOSIS AND INHIBITION OF CELL GROWTH THROUGH 4.33 PROTEIN

Also Published As

Publication number Publication date
US7585497B2 (en) 2009-09-08
EP1290162A4 (en) 2005-08-17
CA2410056A1 (en) 2001-11-22
US20040072285A1 (en) 2004-04-15
WO2001087238A2 (en) 2001-11-22
EP1290162A2 (en) 2003-03-12
US20100120143A1 (en) 2010-05-13
WO2001087238A3 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU5090200A (en) Culture chamber
AU2001229712A1 (en) Reduction of hair growth
AU7620200A (en) Compositions and methods relating to the inhibition of casomorphin and gluteomorphin
AU2001264769A1 (en) Induction of apoptosis and cell growth inhibition by protein 4.33
AUPR030900A0 (en) Growth factor complex
AUPP303498A0 (en) Inhibition of gram positive bacteria
AU2002216223A1 (en) Preservation of cells
AU4187200A (en) The use of domains of type iv collagen t inhibit angiogenesis an tumour growth
WO2000042994A3 (en) Inhibition of bacterial dissemination
AU2591299A (en) Human protein kinase c inhibitor
AU1389801A (en) Modification of plants
AU4774200A (en) Long term cell culture of human carcinoma
AU2002222471A1 (en) Inhibitory agents derived from specific growth factors
AU2002342355A1 (en) Identifying and controlling the growth of estrogen-responsive cells
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU2001285782A1 (en) Regulation of human phosphodiesterase-like enzyme
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme
AU2002215942A1 (en) Regulation of human carboxylesterase-like enzyme
AU2002230889A1 (en) Target enzymes
AU2002212246A1 (en) Regulation of human serine palmitoyltransferase-like enzyme
AU3376501A (en) Improvement of implantation rate
AU5033101A (en) Regulation of human heparanase-like enzyme
AU5647101A (en) Over expression of the whn protein
AU2002217134A1 (en) Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme